I believe as someone on here mentioned before that the

New Post Public Reply Private Reply Replies (1) Message Board
Bravo16 hylander #16785
365
I believe as someone on here mentioned before that the strategy has changed a bit. The S1 for NGIO would probably have already been in had it not been for the pandemic. However the vaccine has the potential to add millions (billions)? to valuation and so they cant submit until they know what their valuation is. You don't want them to undervalue the IPO do you?

GNBT S1? IDK maybe they feel they don't need additional funding if they hit on the vaccine so they are waiting. It sucks to wait but i cant fault them for waiting to see where everything shakes out.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Impact of Indiana Court Ruling on Industry Liability Claims

Updated Category News Views 94

Significance of the Indiana Court Ruling In a landmark decision, the Indiana Court of Appeals unanimously resolved a long-standing legal battle by dismissing a lawsuit against firearm manufacturers initiated by the City of Gary. This case spanned 26 years and sought to place accountability on gun makers for crimes committed by third parties. With this ruling, the court...

Continue Reading
Riot Platforms Shares Key Insights on Bitcoin Production

Updated Category News Views 155

Riot Platforms Shares Key Insights on Bitcoin Production Riot Platforms, Inc. (NASDAQ: RIOT), a leader in the Bitcoin mining industry, recently announced significant updates regarding their production operations for the month of March. The company proudly reported the successful production of 533 Bitcoin during this period, underscoring their commitment to maintaining...

Continue Reading
Telix Pharmaceuticals Advances Kidney Cancer Imaging with TLX250-CDx

Updated Category News Views 162

Telix Pharmaceuticals' Breakthrough in Kidney Cancer Imaging Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX) has made significant strides forward in the field of kidney cancer diagnostics with the FDA's acceptance of its Biologics License Application (BLA) for TLX250-CDx, also known as Zircaix. This important step brings the company closer to potentially...

Continue Reading
Transforming Restaurant Operations: Lightspeed and 7shifts Join Forces

Updated Category News Views 283

Lightspeed and 7shifts Partnership Overview In an exciting development for the restaurant industry, Lightspeed Commerce Inc. has expanded its partnership with 7shifts, a leader in workforce management for restaurants. This collaboration aims to enhance payroll processing and operational efficiency for establishments across North America. Together, they are set to...

Continue Reading
Tint World Achieves Impressive Ranking in Inc. 5000 List

Updated Category News Views 148

Tint World® Achieves Notable Milestone Tint World® Automotive Styling Centers™, renowned for excellence in automotive styling, proudly ranks No. 4,836 on the esteemed Inc. 5000 list of fastest-growing private companies in America. This achievement, underpinned by a remarkable three-year revenue growth of 57.55 percent, marks the tenth occasion Tint World has earned a...

Continue Reading